Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Ellipta

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids
    GSK’s Trelegy Ellipta: US FDA Panel To Weigh Role Of Inhaled Corticosteroids

    27 Aug 2020

    // PINKSHEET

    https://pink.pharmaintelligence.informa.com/PS142810/GSKs-Trelegy-Ellipta-US-FDA-Panel-To-Weigh-Role-Of-Inhaled-Corticosteroids-On-Mortality-Results

    PINKSHEET
    27 Aug 2020
    Share Share
    GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma
    GSK filing accepted by EMA for Trelegy Ellipta use in adult patients with asthma

    27 Feb 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200227005586/en

    BUSINESSWIRE
    27 Feb 2020
    Share Share
    Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs
    Drugmakers from Pfizer to GSK to hike U.S. prices on over 200 drugs

    01 Jan 2020

    // Michael Erman CNBC

    https://www.cnbc.com/2019/12/31/reuters-america-exclusive-drugmakers-from-pfizer-to-gsk-to-hike-u-s-prices-on-over-200-drugs.html

    Michael Erman CNBC
    01 Jan 2020
    Share Share
    GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma
    GSK Submits Filing to FDA for Trelegy Ellipta Use in Patients With Asthma

    03 Oct 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20191002005525/en

    BUSINESSWIRE
    03 Oct 2019
    Share Share
    AstraZeneca's combo lung disease therapy fails to win FDA approval
    AstraZeneca's combo lung disease therapy fails to win FDA approval

    02 Oct 2019

    // A. Jagadeesh REUTERS

    https://www.reuters.com/article/us-astrazeneca-fda/astrazenecas-combo-lung-disease-therapy-fails-to-win-fda-approval-idUSKBN1WG2XH

    A. Jagadeesh REUTERS
    02 Oct 2019
    Share Share
    FDA knocks back AstraZeneca's respiratory ambitions
    FDA knocks back AstraZeneca's respiratory ambitions

    02 Oct 2019

    // J.Gardner BIOPHARMADIVE

    https://www.biopharmadive.com/news/astrazeneca-pt010-fda-rejection-copd-gsk-respiratory-competition/564090/

    J.Gardner BIOPHARMADIVE
    02 Oct 2019
    Share Share